PLTR vs TERN · P/E 584, rev $4.48B vs $6.12B cap
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PLTR and TERN stock pages for the full models.
Not investment advice.